Category : Search result: cannabis research


Trump Order May Reclassify Marijuana, Easing Federal Rules

President Trump's executive order initiates a major shift in U.S. drug policy, potentially moving cannabis to Schedule III. This change could aid medical research and reduce industry taxes. Explore the implications and political divide.

Cannabis stocks climb after Trump eases marijuana curbs

Canadian cannabis stocks experienced a significant rally after former U.S. President Donald Trump signed an executive order to reduce federal restrictions on marijuana. Explore the market impact and what it means for investors.

Trump Admin Targets Colorado Climate Research Center

The White House plans to break up the National Center for Atmospheric Research in Boulder, a move scientists warn will cripple U.S. weather prediction and disaster response. Learn about the potential fallout.

Trump to Sign Executive Order Reclassifying Marijuana

President Trump is expected to sign an executive order reclassifying marijuana, easing federal restrictions on the drug. This major policy shift could have significant implications across North America.

White House Weighs Easing Federal Marijuana Restrictions

The Biden administration is reviewing a historic shift in U.S. drug policy by reclassifying marijuana, a move with significant implications for Canada's cannabis industry and cross-border relations. Read the latest.

Canopy Growth Buys MTL Cannabis for $125M

Canadian cannabis giant Canopy Growth announces a major acquisition of MTL Cannabis, valued at $125 million. The deal aims to strengthen its market position and portfolio. Read the full details here.

Scromiting: Cannabis-Linked Illness Rising in Canada

Cannabis hyperemesis syndrome, known as 'scromiting,' is increasing. Learn about this severe condition linked to long-term marijuana use, its symptoms, and the urgent health warning for Canadians.

Page 1 of 4